Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $674.24 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $271.24 | 3 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $143.66 | 2 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $124.30 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $101.49 | 1 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $33.55 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $158.54 | 2 | Otsuka America Pharmaceutical, Inc. ($124.99) |
| 2023 | $124.99 | 1 | Otsuka America Pharmaceutical, Inc. ($124.99) |
| 2022 | $143.16 | 2 | Sunovion Pharmaceuticals Inc. ($124.30) |
| 2021 | $124.80 | 1 | Avanir Pharmaceuticals, Inc. ($124.80) |
| 2019 | $21.26 | 1 | Otsuka America Pharmaceutical, Inc. ($21.26) |
| 2017 | $101.49 | 1 | Merck Sharp & Dohme Corporation ($101.49) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $33.55 | General |
| Category: Neuropsychiatry | ||||||
| 03/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 04/20/2022 | Sunovion Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $124.30 | General |
| 02/23/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 11/04/2021 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 03/14/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2017 | Merck Sharp & Dohme Corporation | ZOSTAVAX (Biological), PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $101.49 | General |
| Category: VACCINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 188 | 198 | $100,294 | $24,054 |
| 2022 | 4 | 226 | 254 | $111,862 | $26,117 |
| 2021 | 4 | 161 | 175 | $68,237 | $18,153 |
| 2020 | 2 | 55 | 55 | $24,151 | $6,909 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 74 | 76 | $46,512 | $11,448 | 24.6% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 56 | 56 | $26,656 | $6,184 | 23.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 35 | 42 | $14,070 | $3,383 | 24.0% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 12 | 12 | $7,344 | $1,808 | 24.6% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 11 | 12 | $5,712 | $1,232 | 21.6% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 86 | 88 | $39,979 | $9,356 | 23.4% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 63 | 64 | $37,399 | $8,931 | 23.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 30 | 47 | $15,009 | $3,394 | 22.6% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 29 | 29 | $13,183 | $3,113 | 23.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 18 | 26 | $6,292 | $1,322 | 21.0% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 64 | 65 | $26,743 | $7,041 | 26.3% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 35 | 35 | $18,264 | $4,946 | 27.1% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2021 | 26 | 27 | $11,061 | $2,998 | 27.1% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 18 | 23 | $6,650 | $1,786 | 26.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 18 | 25 | $5,519 | $1,383 | 25.1% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2020 | 25 | 25 | $12,485 | $3,593 | 28.8% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2020 | 30 | 30 | $11,666 | $3,317 | 28.4% |
About Dr. Jesse Chua-Reyes, M.D
Dr. Jesse Chua-Reyes, M.D is a Geriatric Medicine healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1669473724.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jesse Chua-Reyes, M.D has received a total of $674.24 in payments from pharmaceutical and medical device companies, with $158.54 received in 2024. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($674.24).
As a Medicare-enrolled provider, Chua-Reyes has provided services to 630 Medicare beneficiaries, totaling 682 services with total Medicare billing of $75,233. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Geriatric Medicine
- Location New Haven, CT
- Active Since 08/10/2005
- Last Updated 01/09/2009
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1669473724
Products in Payments
- REXULTI (Drug) $271.24
- NUEDEXTA (Drug) $124.80
- ZOSTAVAX (Biological) $101.49
- INGREZZA (Drug) $33.55
- Nuedexta (Drug) $18.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in New Haven
Dr. Susann Varano, Md, MD
Geriatric Medicine — Payments: $61,923
Henry Yaggi, Md, MD
Geriatric Medicine — Payments: $9,513
Thomas Gill, Md, MD
Geriatric Medicine — Payments: $2,693
Dr. Loren Greenberg, Ms, Md, MS, MD
Geriatric Medicine — Payments: $430.36
Leen Bakkali, Md, MD
Geriatric Medicine — Payments: $264.84
Ronald Miller, M.d, M.D
Geriatric Medicine — Payments: $154.70